Heartflow, Inc.HTFL财报
Nasdaq · 医疗保健 · 外科及医疗仪器和设备
Heartflow是一家专注于非侵入式心血管诊断解决方案的医疗科技企业，核心技术可通过CT扫描数据构建患者冠状动脉3D模型，评估血流状况以识别血管堵塞，辅助临床医生制定个性化心脏病诊疗方案，服务全球医疗机构。
内部人交易
Net 90d: −$4.61M · buys $0 / sells $4.61M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-04-10 | Farquhar John C.M. | Chief Executive Officer | Sell (open market) | 22.6K | $26.72 | $602.9K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 291 | $8.33 | $2.4K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 19.1K | $2.22 | $42.4K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 40.8K | $2.22 | $90.5K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 6.8K | $2.22 | $15.2K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Sell (open market) | 64.5K | $24.64 | $1.59M |
| 2026-03-24 | HealthCor Partners Management LP | Director | Other | 4.62M | — | — |
| 2026-03-24 | Lightcap Jeffrey C | Director | Other | 206.3K | $0.00 | $0 |
| 2026-03-19 | Campbell Rogers | Chief Medical Officer | Option exercise | 19.4K | $2.22 | $43.1K |
| 2026-03-19 | Campbell Rogers | Chief Medical Officer | Option exercise | 47.6K | $2.22 | $105.7K |
1–10 of 16
第 1 页 / 共 2 页